News | Ultrasound Women's Health | January 13, 2017

Sofia 3-D Breast Ultrasound Receives Innovative Technology Designation from Vizient

Designation recognizes products that bring improvements to the healthcare industry

Hitachi Aloka, Sofia 3-D Breast Ultrasound, Innovative Technology Designation, Vizient Inc., RSNA 2016

January 13, 2017 — Hitachi Aloka Medical America Inc. announced in November that the Sofia 3-D Breast Ultrasound system received an Innovative Technology designation from Vizient Inc., the largest member-driven healthcare performance improvement company in the country. The designation was based on reviews of Sofia by hospital experts who attended Vizient’s Innovative Technology Exchange in September 2016. The event provided medical technology suppliers the opportunity to demonstrate their product and gain direct feedback from 1,300 onsite clinical experts and healthcare providers on the impact their products may have on improving clinical care and safety, or benefits to an organization’s care and business model.

Designed for women whose breast density may result in an inconclusive mammogram, Sofia uses ultrasound to create a 3-D volume of the whole breast. Patients are imaged in the prone position, placing their breast onto Sofia’s radial scanning array.  With the breast compressed simply by laying prone, the patient rests comfortably during the system’s rapid automated 30-second scan. The acquired high-resolution ultrasound images are then sent to the Sofia workstation and reconstructed into a 3-D volume of the entire breast that can be quickly interpreted by the radiologist.

“Due to the number of products and services being released and marketed as ‘innovative’, member hospitals truly value the peer-review system in place at Vizient to help them identify products worth further evaluation at their own facilities,” said Debbie Archer, director of procurement and leader of Vizient’s Innovative Technology program for suppliers.  “After a review of Sofia 3-D Breast Ultrasound system, Vizient’s members agreed this solution offers unique and incremental benefit over other products available on the market today, and recommended it for an Innovative Technology designation.”

For more information: www.hitachi-aloka.com

Related Content

Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...